Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in Ann Nucl Med

Retrieve available abstracts of 140 articles:
HTML format
Text format



Single Articles


    November 2018
  1. INOUE Y, Nagahara K, Inoki Y, Hara T, et al
    Clinical evaluation of CT radiation dose in whole-body (18)F-FDG PET/CT in relation to scout imaging direction and arm position.
    Ann Nucl Med. 2018 Nov 10. pii: 10.1007/s12149-018-1318.
    PubMed     Text format     Abstract available


  2. JORAKU A, Hatano K, Kawai K, Kandori S, et al
    Phase I/IIa PET imaging study with (89)zirconium labeled anti-PSMA minibody for urological malignancies.
    Ann Nucl Med. 2018 Nov 7. pii: 10.1007/s12149-018-1312.
    PubMed     Text format     Abstract available


  3. ZHENG S, Chen Z, Huang C, Chen Y, et al
    [(99m)Tc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [(18)F]FDG PET/CT.
    Ann Nucl Med. 2018 Nov 3. pii: 10.1007/s12149-018-1315.
    PubMed     Text format     Abstract available


  4. KAMEYAMA M, Watanabe K
    A new non-invasive graphical method for quantification of cerebral blood flow with[[Formula: see text]] IMP.
    Ann Nucl Med. 2018;32:620-626.
    PubMed     Text format     Abstract available


  5. TAKAMI Y, Yamamoto Y, Ueno M, Chiba Y, et al
    Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with human equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in patients with newly diagnosed gliomas.
    Ann Nucl Med. 2018;32:634-641.
    PubMed     Text format     Abstract available


  6. SETTA K, Kojima D, Shimada Y, Yoshida J, et al
    Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.
    Ann Nucl Med. 2018;32:611-619.
    PubMed     Text format     Abstract available


  7. USMANI S, Van den Wyngaert T, Ahmed N, Marafi F, et al
    Technical feasibility, radiation dosimetry and clinical use of (18)F-sodium fluoride (NaF) in evaluation of metastatic bone disease in pediatric population.
    Ann Nucl Med. 2018;32:594-601.
    PubMed     Text format     Abstract available


    October 2018
  8. TADESSE GF, Geramifar P, Tegaw EM, Ay MR, et al
    Techniques for generating attenuation map using cardiac SPECT emission data only: a systematic review.
    Ann Nucl Med. 2018 Oct 22. pii: 10.1007/s12149-018-1311.
    PubMed     Text format     Abstract available


  9. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Characteristics of iodine-123 IQ-SPECT/CT imaging compared with conventional SPECT/CT.
    Ann Nucl Med. 2018 Oct 15. pii: 10.1007/s12149-018-1310.
    PubMed     Text format     Abstract available


  10. KOH YW, Lee SJ, Park SY
    (18)F-fluorodeoxyglucose positron emission tomography is correlated with the pathological necrosis and decreased microvessel density in lung adenocarcinomas.
    Ann Nucl Med. 2018 Oct 15. pii: 10.1007/s12149-018-1309.
    PubMed     Text format     Abstract available


  11. SHIBUTANI T, Nakajima K, Wakabayashi H, Mori H, et al
    Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT.
    Ann Nucl Med. 2018 Oct 9. pii: 10.1007/s12149-018-1306.
    PubMed     Text format     Abstract available


  12. SASAMORI H, Uno K, Wu J
    Usefulness of both PET/CT with F18-FDG and whole-body diffusion-weighted imaging in cancer screening: a preliminary report.
    Ann Nucl Med. 2018 Oct 8. pii: 10.1007/s12149-018-1307.
    PubMed     Text format     Abstract available


  13. BRUMBERG J, Tran-Gia J, Lapa C, Isaias IU, et al
    PET imaging of noradrenaline transporters in Parkinson's disease: focus on scan time.
    Ann Nucl Med. 2018 Oct 6. pii: 10.1007/s12149-018-1305.
    PubMed     Text format     Abstract available


  14. RAHMAN MGM, Islam MM, Tsujikawa T, Kiyono Y, et al
    Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
    Ann Nucl Med. 2018 Oct 1. pii: 10.1007/s12149-018-1297.
    PubMed     Text format     Abstract available


    September 2018
  15. INUBUSHI M, Tatsumi M, Yamamoto Y, Kato K, et al
    European research trends in nuclear medicine.
    Ann Nucl Med. 2018 Sep 21. pii: 10.1007/s12149-018-1303.
    PubMed     Text format     Abstract available


  16. PALARD-NOVELLO X, Beuzit L, Gambarota G, Le Jeune F, et al
    Comparison of (18)F-Choline PET/CT and MRI functional parameters in prostate cancer.
    Ann Nucl Med. 2018 Sep 15. pii: 10.1007/s12149-018-1302.
    PubMed     Text format     Abstract available


  17. ANWAR H, Vogl TJ, Abougabal MA, Grunwald F, et al
    The value of different (18)F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients.
    Ann Nucl Med. 2018 Sep 15. pii: 10.1007/s12149-018-1301.
    PubMed     Text format     Abstract available


  18. LV N, Gao S, Bai L, Ji B, et al
    Advantages of (99m)Tc-3PRGD2 SPECT over CT in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.
    Ann Nucl Med. 2018 Sep 14. pii: 10.1007/s12149-018-1300.
    PubMed     Text format     Abstract available


  19. XU J, Li Y, Hu S, Lu L, et al
    The significant value of predicting prognosis in patients with colorectal cancer using (18)F-FDG PET metabolic parameters of primary tumors and hematological parameters.
    Ann Nucl Med. 2018 Sep 14. pii: 10.1007/s12149-018-1299.
    PubMed     Text format     Abstract available


  20. KITAO T, Shiga T, Hirata K, Sekizawa M, et al
    Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
    Ann Nucl Med. 2018 Sep 8. pii: 10.1007/s12149-018-1298.
    PubMed     Text format     Abstract available


  21. BESHR R, Isohashi K, Watabe T, Naka S, et al
    Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [(18)F]fluoro-borono-phenylalanine PET/CT.
    Ann Nucl Med. 2018 Sep 7. pii: 10.1007/s12149-018-1296.
    PubMed     Text format     Abstract available


  22. INOUE Y, Hara T, Ikari T, Takahashi K, et al
    Super-early images of brain perfusion SPECT using (123)I-IMP for the assessment of hyperperfusion in stroke patients.
    Ann Nucl Med. 2018 Sep 1. pii: 10.1007/s12149-018-1293.
    PubMed     Text format     Abstract available


    August 2018
  23. VALOTASSIOU V, Malamitsi J, Papatriantafyllou J, Dardiotis E, et al
    SPECT and PET imaging in Alzheimer's disease.
    Ann Nucl Med. 2018 Aug 20. pii: 10.1007/s12149-018-1292.
    PubMed     Text format     Abstract available


  24. NAKANISHI Y, Kitajima K, Yamada Y, Hashimoto T, et al
    Diagnostic performance of (11)C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer.
    Ann Nucl Med. 2018 Aug 17. pii: 10.1007/s12149-018-1287.
    PubMed     Text format     Abstract available


  25. HAN S, Kim H, Kim YJ, Suh CH, et al
    Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in ovarian cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2018 Aug 12. pii: 10.1007/s12149-018-1289.
    PubMed     Text format     Abstract available


  26. YOO J, Kim BS, Yoon HJ
    Predictive value of primary tumor parameters using (18)F-FDG PET/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node.
    Ann Nucl Med. 2018 Aug 9. pii: 10.1007/s12149-018-1288.
    PubMed     Text format     Abstract available


  27. SEIDER MJ, Pugh SL, Langer C, Wyatt G, et al
    Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.
    Ann Nucl Med. 2018 Aug 9. pii: 10.1007/s12149-018-1278.
    PubMed     Text format     Abstract available


  28. ISHIWATA K, Ebinuma R, Watanabe C, Hayashi K, et al
    Reliable radiosynthesis of 4-[(10)B]borono-2-[(18)F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.
    Ann Nucl Med. 2018;32:463-473.
    PubMed     Text format     Abstract available


  29. KATSUURA T, Kitajima K, Fujiwara M, Terada T, et al
    Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
    Ann Nucl Med. 2018;32:453-462.
    PubMed     Text format     Abstract available


  30. MAIR C, Warwitz B, Fink K, Scarpa L, et al
    Radiation exposure after (177)Lu-DOTATATE and (177)Lu-PSMA-617 therapy.
    Ann Nucl Med. 2018;32:499-502.
    PubMed     Text format     Abstract available


  31. PAK K, Nam HY, Shin S, Kim K, et al
    Effects of rs591323 on serotonin transporter availability in healthy male subjects.
    Ann Nucl Med. 2018;32:431-436.
    PubMed     Text format     Abstract available


    July 2018
  32. MITAMURA K, Yamamoto Y, Norikane T, Hatakeyama T, et al
    Correlation of (18)F-FDG and (11)C-methionine uptake on PET/CT with Ki-67 immunohistochemistry in newly diagnosed intracranial meningiomas.
    Ann Nucl Med. 2018 Jul 21. pii: 10.1007/s12149-018-1284.
    PubMed     Text format     Abstract available


  33. HAN S, Woo S, Suh CH, Kim YJ, et al
    A systematic review of the prognostic value of texture analysis in (18)F-FDG PET in lung cancer.
    Ann Nucl Med. 2018 Jul 16. pii: 10.1007/s12149-018-1281.
    PubMed     Text format     Abstract available


  34. HIGASHIYAMA A, Komori T, Juri H, Inada Y, et al
    Detectability of residual invasive bladder cancer in delayed (18)F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.
    Ann Nucl Med. 2018 Jul 16. pii: 10.1007/s12149-018-1280.
    PubMed     Text format     Abstract available


  35. KOMEK H, Can C, Yilmaz U, Altindag S, et al
    Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer.
    Ann Nucl Med. 2018 Jul 13. pii: 10.1007/s12149-018-1277.
    PubMed     Text format     Abstract available


  36. ALBANO D, Bertoli M, Battistotti M, Rodella C, et al
    Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
    Ann Nucl Med. 2018 Jul 7. pii: 10.1007/s12149-018-1274.
    PubMed     Text format     Abstract available


  37. RINGHEIM A, Campos Neto GC, Martins KM, Vitor T, et al
    Reproducibility of standardized uptake values of same-day randomized (68)Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients.
    Ann Nucl Med. 2018 Jul 7. pii: 10.1007/s12149-018-1275.
    PubMed     Text format     Abstract available


  38. LEE SH, Sung C, Lee HS, Yoon HY, et al
    Is (18)F-FDG PET/CT useful for the differential diagnosis of solitary pulmonary nodules in patients with idiopathic pulmonary fibrosis?
    Ann Nucl Med. 2018 Jul 4. pii: 10.1007/s12149-018-1273.
    PubMed     Text format     Abstract available


  39. KURISU S, Nitta K, Sumimoto Y, Ikenaga H, et al
    Implications of electrocardiographic frontal QRS axis on left ventricular diastolic parameters derived from electrocardiogram-gated myocardial perfusion single photon emission computed tomography.
    Ann Nucl Med. 2018;32:404-409.
    PubMed     Text format     Abstract available


  40. TEMMA T, Kondo N, Yoda K, Nishigori K, et al
    Comparison of (125)I- and (111)In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques.
    Ann Nucl Med. 2018;32:425-429.
    PubMed     Text format     Abstract available


    June 2018
  41. AOE J, Watabe T, Shimosegawa E, Kato H, et al
    Evaluation of the default-mode network by quantitative (15)O-PET: comparative study between cerebral blood flow and oxygen consumption.
    Ann Nucl Med. 2018 Jun 22. pii: 10.1007/s12149-018-1272.
    PubMed     Text format     Abstract available


  42. HEMMATI H, Kamali-Asl A, Ghafarian P, Ay MR, et al
    Reconstruction/segmentation of attenuation map in TOF-PET based on mixture models.
    Ann Nucl Med. 2018 Jun 21. pii: 10.1007/s12149-018-1270.
    PubMed     Text format     Abstract available


  43. PARVEZ A, Tau N, Hussey D, Maganti M, et al
    Publisher Correction to: (18)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
    Ann Nucl Med. 2018 Jun 20. pii: 10.1007/s12149-018-1271.
    PubMed     Text format     Abstract available


  44. XU J, Li Y, Xu X, Zhang J, et al
    Clinical application of (99m)Tc-HYNIC-TOC SPECT/CT in diagnosing and monitoring of pancreatic neuroendocrine neoplasms.
    Ann Nucl Med. 2018 Jun 20. pii: 10.1007/s12149-018-1266.
    PubMed     Text format     Abstract available


  45. YUGE S, Nakatani K, Yoshino K, Koyama T, et al
    Diagnosing polymyalgia rheumatica on (18)F-FDG PET/CT: typical uptake patterns.
    Ann Nucl Med. 2018 Jun 8. pii: 10.1007/s12149-018-1269.
    PubMed     Text format     Abstract available


  46. MOLINA-GARCIA D, Garcia-Vicente AM, Perez-Beteta J, Amo-Salas M, et al
    Intratumoral heterogeneity in (18)F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate.
    Ann Nucl Med. 2018 Jun 5. pii: 10.1007/s12149-018-1253.
    PubMed     Text format     Abstract available


  47. LEBASNIER A, Legallois D, Bienvenu B, Bergot E, et al
    Diagnostic value of quantitative assessment of cardiac (18)F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.
    Ann Nucl Med. 2018;32:319-327.
    PubMed     Text format     Abstract available


  48. YOO J, Kim BS, Yoon HJ
    Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Ann Nucl Med. 2018;32:328-336.
    PubMed     Text format     Abstract available


  49. NAKAJIMA K, Okuda K, Watanabe S, Matsuo S, et al
    Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database.
    Ann Nucl Med. 2018;32:303-310.
    PubMed     Text format     Abstract available


    May 2018
  50. CAOBELLI F, Chiaravalloti A, Evangelista L, Saladini G, et al
    Correction to: Predictive and prognostic value of (18)F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Ann Nucl Med. 2018 May 24. pii: 10.1007/s12149-018-1265.
    PubMed     Text format     Abstract available


  51. CHOI JH, Lim I, Noh WC, Kim HA, et al
    Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.
    Ann Nucl Med. 2018 May 23. pii: 10.1007/s12149-018-1259.
    PubMed     Text format     Abstract available


  52. KAMEI R, Watanabe Y, Sagiyama K, Isoda T, et al
    Optimal monochromatic color combinations for fusion imaging of FDG-PET and diffusion-weighted MR images.
    Ann Nucl Med. 2018 May 23. pii: 10.1007/s12149-018-1263.
    PubMed     Text format     Abstract available


  53. PARVEZ A, Tau N, Hussey D, Maganti M, et al
    (718)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
    Ann Nucl Med. 2018 May 12. pii: 10.1007/s12149-018-1260.
    PubMed     Text format     Abstract available


  54. SAUERBECK J, Ishii K, Hosokawa C, Kaida H, et al
    The correlation between striatal and cortical binding ratio of (11)C-PiB-PET in amyloid-uptake-positive patients.
    Ann Nucl Med. 2018 May 5. pii: 10.1007/s12149-018-1258.
    PubMed     Text format     Abstract available


  55. LIU S, Gu B, Zhang J, Zhang Y, et al
    The feasibility of (18)F-FES and (18)F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERalpha in ERalpha+ breast cancer.
    Ann Nucl Med. 2018;32:272-280.
    PubMed     Text format     Abstract available


    April 2018
  56. ISHIGUCHI H, Ito S, Kato K, Sakurai Y, et al
    Diagnostic performance of (18)F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ann Nucl Med. 2018 Apr 17. pii: 10.1007/s12149-018-1254.
    PubMed     Text format     Abstract available


  57. IWABUCHI Y, Nakahara T, Kameyama M, Yamada Y, et al
    Quantitative evaluation of the tracer distribution in dopamine transporter SPECT for objective interpretation.
    Ann Nucl Med. 2018 Apr 13. pii: 10.1007/s12149-018-1256.
    PubMed     Text format     Abstract available


  58. WATANABE M, Nakamoto Y, Koyasu S, Ishimori T, et al
    The influence of elevated hormone levels on physiologic accumulation of (68)Ga-DOTATOC.
    Ann Nucl Med. 2018;32:191-196.
    PubMed     Text format     Abstract available


  59. HOSONO M, Ikebuchi H, Nakamura Y, Nakamura N, et al
    Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.).
    Ann Nucl Med. 2018;32:217-235.
    PubMed     Text format     Abstract available


    March 2018
  60. BEXELIUS T, Sohlberg A
    Implementation of GPU accelerated SPECT reconstruction with Monte Carlo-based scatter correction.
    Ann Nucl Med. 2018 Mar 21. pii: 10.1007/s12149-018-1252.
    PubMed     Text format     Abstract available


  61. INUI Y, Ichihara T, Uno M, Ishiguro M, et al
    CT-based attenuation correction and resolution compensation for I-123 IMP brain SPECT normal database: a multicenter phantom study.
    Ann Nucl Med. 2018 Mar 19. pii: 10.1007/s12149-018-1248.
    PubMed     Text format     Abstract available


  62. MIZUMURA S, Nishikawa K, Murata A, Yoshimura K, et al
    Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.
    Ann Nucl Med. 2018 Mar 15. pii: 10.1007/s12149-018-1249.
    PubMed     Text format     Abstract available


    February 2018
  63. PALARD-NOVELLO X, Blin AL, Bourhis D, Garin E, et al
    Comparison of choline influx from dynamic (18)F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment.
    Ann Nucl Med. 2018 Feb 28. pii: 10.1007/s12149-018-1246.
    PubMed     Text format     Abstract available


  64. TSUJIKAWA T, Narita N, Kanno M, Takabayashi T, et al
    Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.
    Ann Nucl Med. 2018 Feb 27. pii: 10.1007/s12149-018-1244.
    PubMed     Text format     Abstract available


  65. SIMSEK DH, Sanli Y, Kuyumcu S, Basaran B, et al
    (68)Ga-DOTATATE PET-CT imaging in carotid body paragangliomas.
    Ann Nucl Med. 2018 Feb 21. pii: 10.1007/s12149-018-1242.
    PubMed     Text format     Abstract available


  66. ANNUNZIATA S, Cuccaro A, Tisi MC, Hohaus S, et al
    FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).
    Ann Nucl Med. 2018 Feb 20. pii: 10.1007/s12149-018-1243.
    PubMed     Text format     Abstract available


  67. NISHII R, Higashi T, Kagawa S, Okuyama C, et al
    (18)F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man (18)F-FPYBF-2 PET imaging.
    Ann Nucl Med. 2018 Feb 16. pii: 10.1007/s12149-018-1240.
    PubMed     Text format     Abstract available


  68. TORIIHARA A, Ohtake M, Tateishi K, Hino-Shishikura A, et al
    Prognostic implications of (62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET/CT in patients with glioma.
    Ann Nucl Med. 2018 Feb 16. pii: 10.1007/s12149-018-1241.
    PubMed     Text format     Abstract available


  69. OZDERYA A, Temizkan S, Gul AE, Ozugur S, et al
    Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism.
    Ann Nucl Med. 2018 Feb 5. pii: 10.1007/s12149-018-1239.
    PubMed     Text format     Abstract available


  70. HABERT MO, Bertin H, Labit M, Diallo M, et al
    Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds.
    Ann Nucl Med. 2018;32:75-86.
    PubMed     Text format     Abstract available


    January 2018
  71. HIGASHI T, Nishii R, Kagawa S, Kishibe Y, et al
    (18)F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.
    Ann Nucl Med. 2018 Jan 31. pii: 10.1007/s12149-018-1236.
    PubMed     Text format     Abstract available


  72. DONG W, Li J, Mi H, Song X, et al
    Relationship between collateral circulation and myocardial viability of (18)F-FDG PET/CT subtended by chronic total occluded coronary arteries.
    Ann Nucl Med. 2018 Jan 29. pii: 10.1007/s12149-018-1234.
    PubMed     Text format     Abstract available


  73. TSUJIMOTO M, Teramoto A, Ota S, Toyama H, et al
    Automated segmentation and detection of increased uptake regions in bone scintigraphy using SPECT/CT images.
    Ann Nucl Med. 2018 Jan 27. pii: 10.1007/s12149-018-1237.
    PubMed     Text format     Abstract available


  74. ARORA G, Bandopadhyaya G
    Paradigm shift in theranostics of neuroendocrine tumors: conceptual horizons of nanotechnology in nuclear medicine.
    Ann Nucl Med. 2018 Jan 27. pii: 10.1007/s12149-018-1235.
    PubMed     Text format     Abstract available


  75. NAKAJIMA K, Okuda K, Matsuo S, Wakabayashi H, et al
    Is (123)I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.
    Ann Nucl Med. 2018 Jan 15. pii: 10.1007/s12149-018-1231.
    PubMed     Text format     Abstract available


  76. GERBAUDO VH, Killoran JH, Kim CK, Hornick JL, et al
    Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
    Ann Nucl Med. 2018 Jan 13. pii: 10.1007/s12149-018-1229.
    PubMed     Text format     Abstract available


  77. KARTAMIHARDJA AHS, Kurniawati Y, Gunawan R
    Diagnostic value of (99m)Tc-ethambutol scintigraphy in tuberculosis: compared to microbiological and histopathological tests.
    Ann Nucl Med. 2018;32:60-68.
    PubMed     Text format     Abstract available


    December 2017
  78. KITS A, Martin H, Sanchez-Crespo A, Delgado AF, et al
    Diagnostic accuracy of (11)C-methionine PET in detecting neuropathologically confirmed recurrent brain tumor after radiation therapy.
    Ann Nucl Med. 2017 Dec 26. pii: 10.1007/s12149-017-1227.
    PubMed     Text format     Abstract available


  79. GARCIA-VICENTE AM, Tello-Galan MJ, Amo-Salas M, Ros-Izquierdo J, et al
    Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin?
    Ann Nucl Med. 2017 Dec 20. pii: 10.1007/s12149-017-1226.
    PubMed     Text format     Abstract available


  80. UMEDA T, Koizumi M, Fukai S, Miyaji N, et al
    Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Ann Nucl Med. 2017 Dec 14. pii: 10.1007/s12149-017-1224.
    PubMed     Text format     Abstract available


  81. CHEIMARIOTIS GA, Al-Mashat M, Haris K, Aletras AH, et al
    Automatic lung segmentation in functional SPECT images using active shape models trained on reference lung shapes from CT.
    Ann Nucl Med. 2017 Dec 13. pii: 10.1007/s12149-017-1223.
    PubMed     Text format     Abstract available


  82. JONES KM, Solnes LB, Rowe SP, Gorin MA, et al
    Use of quantitative SPECT/CT reconstruction in (99m)Tc-sestamibi imaging of patients with renal masses.
    Ann Nucl Med. 2017 Dec 6. pii: 10.1007/s12149-017-1222.
    PubMed     Text format     Abstract available


    November 2017
  83. SATHEKGE M, Garcia-Perez O, Paez D, El-Haj N, et al
    Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT.
    Ann Nucl Med. 2017 Nov 21. doi: 10.1007/s12149-017-1219.
    PubMed     Text format     Abstract available


  84. LI T, Wu NY, Song N, Mok GSP, et al
    Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry.
    Ann Nucl Med. 2017 Nov 15. doi: 10.1007/s12149-017-1218.
    PubMed     Text format     Abstract available


  85. KITAJIMA K, Miyoshi Y, Yamano T, Odawara S, et al
    Prognostic value of FDG-PET and DWI in breast cancer.
    Ann Nucl Med. 2017 Nov 13. doi: 10.1007/s12149-017-1217.
    PubMed     Text format     Abstract available


  86. SANLI Y, Kuyumcu S, Sanli O, Buyukkaya F, et al
    Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Ann Nucl Med. 2017;31:709-717.
    PubMed     Text format     Abstract available


  87. KURISU S, Sumimoto Y, Ikenaga H, Ishibashi K, et al
    Effects of chronic kidney disease on myocardial washout rate of thallium-201 in patients with normal myocardial perfusion on single photon emission computed tomography.
    Ann Nucl Med. 2017;31:703-708.
    PubMed     Text format     Abstract available


  88. WERNER RA, Sheikhbahaei S, Jones KM, Javadi MS, et al
    Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.
    Ann Nucl Med. 2017;31:696-702.
    PubMed     Text format     Abstract available


    October 2017
  89. CAMPBELL SP, Baras AS, Ball MW, Kates M, et al
    Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma.
    Ann Nucl Med. 2017 Oct 24. doi: 10.1007/s12149-017-1216.
    PubMed     Text format     Abstract available


  90. AMAKUSA S, Matsuoka K, Kawano M, Hasegawa K, et al
    Influence of region-of-interest determination on measurement of signal-to-noise ratio in liver on PET images.
    Ann Nucl Med. 2017 Oct 20. doi: 10.1007/s12149-017-1215.
    PubMed     Text format     Abstract available


  91. KIRIYAMA T, Fukushima Y, Hayashi H, Takano H, et al
    Feasibility of combined risk stratification with coronary CT angiography and stress myocardial SPECT in patients with chronic coronary artery disease.
    Ann Nucl Med. 2017 Oct 6. doi: 10.1007/s12149-017-1214.
    PubMed     Text format     Abstract available


  92. CAOBELLI F, Chiaravalloti A, Evangelista L, Saladini G, et al
    Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Ann Nucl Med. 2017 Oct 6. doi: 10.1007/s12149-017-1213.
    PubMed     Text format     Abstract available


  93. MASAKI Y, Shimizu Y, Yoshioka T, Nishijima KI, et al
    FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
    Ann Nucl Med. 2017;31:596-604.
    PubMed     Text format     Abstract available


    September 2017
  94. NAKAJIMA K, Okuda K, Momose M, Matsuo S, et al
    IQ.SPECT technology and its clinical applications using multicenter normal databases.
    Ann Nucl Med. 2017 Sep 22. doi: 10.1007/s12149-017-1210.
    PubMed     Text format     Abstract available


  95. KROISS AS, Nekolla SG, Dobrozemsky G, Grubinger T, et al
    CT-based SPECT attenuation correction and assessment of infarct size: results from a cardiac phantom study.
    Ann Nucl Med. 2017 Sep 21. doi: 10.1007/s12149-017-1211.
    PubMed     Text format     Abstract available


  96. OKIZAKI A, Nakayama M, Nakajima K, Katayama T, et al
    Inter- and intra-observer reproducibility of quantitative analysis for FP-CIT SPECT in patients with DLB.
    Ann Nucl Med. 2017 Sep 14. doi: 10.1007/s12149-017-1209.
    PubMed     Text format     Abstract available


  97. TSUJIKAWA T, Yamamoto M, Shono K, Yamada S, et al
    Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an 18F-FDG PET/CT texture analysis.
    Ann Nucl Med. 2017 Sep 13. doi: 10.1007/s12149-017-1208.
    PubMed     Text format     Abstract available


  98. GARCIA-VICENTE AM, Molina D, Perez-Beteta J, Amo-Salas M, et al
    Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
    Ann Nucl Med. 2017 Sep 8. doi: 10.1007/s12149-017-1203.
    PubMed     Text format     Abstract available


  99. SUGIHARA T, Koizumi M, Koyama M, Terauchi T, et al
    Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
    Ann Nucl Med. 2017 Sep 1. doi: 10.1007/s12149-017-1202.
    PubMed     Text format     Abstract available


    August 2017
  100. TSUJIKAWA T, Rahman T, Yamamoto M, Yamada S, et al
    18F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer.
    Ann Nucl Med. 2017 Aug 16. doi: 10.1007/s12149-017-1199.
    PubMed     Text format     Abstract available


  101. YAMASHITA S, Yamamoto H, Nakaichi T, Yoneyama T, et al
    Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body 18F-fluorodeoxyglucose positron emission tomography with the same acquisition duration.
    Ann Nucl Med. 2017 Aug 16. doi: 10.1007/s12149-017-1200.
    PubMed     Text format     Abstract available


  102. YADA N, Onishi H, Miyai M, Ozasa K, et al
    Effect of resolution recovery using graph plots on regional cerebral blood flow in healthy volunteers.
    Ann Nucl Med. 2017;31:553-562.
    PubMed     Text format     Abstract available


    July 2017
  103. CHEN L, Tsui BMW, Mok GSP
    Design and evaluation of two multi-pinhole collimators for brain SPECT.
    Ann Nucl Med. 2017 Jul 28. doi: 10.1007/s12149-017-1195.
    PubMed     Text format     Abstract available


  104. INUBUSHI M, Kaneta T, Ishimori T, Imabayashi E, et al
    Topics of nuclear medicine research in Europe.
    Ann Nucl Med. 2017 Jul 25. doi: 10.1007/s12149-017-1198.
    PubMed     Text format     Abstract available


  105. ISIK EG, Kuyumcu S, Kebudi R, Sanli Y, et al
    Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to DeltaSUVmax, Deauville 5-point scale and IHP criteria.
    Ann Nucl Med. 2017 Jul 24. doi: 10.1007/s12149-017-1196.
    PubMed     Text format     Abstract available


  106. ITO S, Endo A, Okada T, Nakamura T, et al
    Comparison of CTAC and prone imaging for the detection of coronary artery disease using CZT SPECT.
    Ann Nucl Med. 2017 Jul 10. doi: 10.1007/s12149-017-1194.
    PubMed     Text format     Abstract available


  107. HOWARD BA, Morgan R, Thorpe MP, Turkington TG, et al
    Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1192.
    PubMed     Text format     Abstract available


  108. NAKAJIMA K, Okuda K, Yokoyama K, Yoneyama T, et al
    Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1191.
    PubMed     Text format     Abstract available


  109. SANTHOSH S, Mittal BR, Bhasin DK, Rana SS, et al
    Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1193.
    PubMed     Text format     Abstract available


  110. HIGASHI K, Ueda Y, Shimasaki M, Ishigaki Y, et al
    High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
    Ann Nucl Med. 2017 Jul 4. doi: 10.1007/s12149-017-1187.
    PubMed     Text format     Abstract available


  111. ZHENG J, Miao W, Huang C, Lin H, et al
    Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging.
    Ann Nucl Med. 2017;31:486-494.
    PubMed     Text format     Abstract available


    June 2017
  112. CHENG L, Zhang J, Wang Y, Xu X, et al
    Textural features of 18F-FDG PET after two cycles of neoadjuvant chemotherapy can predict pCR in patients with locally advanced breast cancer.
    Ann Nucl Med. 2017 Jun 23. doi: 10.1007/s12149-017-1184.
    PubMed     Text format     Abstract available


  113. SHIDAHARA M, Thomas BA, Okamura N, Ibaraki M, et al
    A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.
    Ann Nucl Med. 2017 Jun 21. doi: 10.1007/s12149-017-1185.
    PubMed     Text format     Abstract available


  114. NIKAKI A, Angelidis G, Efthimiadou R, Tsougos I, et al
    18F-fluorothymidine PET imaging in gliomas: an update.
    Ann Nucl Med. 2017 Jun 13. doi: 10.1007/s12149-017-1183.
    PubMed     Text format     Abstract available


  115. ISHIBASHI M, Tanabe Y, Fujii S, Ogawa T, et al
    Pictorial review of 18F-FDG PET/CT findings in musculoskeletal lesions.
    Ann Nucl Med. 2017 Jun 5. doi: 10.1007/s12149-017-1182.
    PubMed     Text format     Abstract available


  116. KATAGIRI M, Nakahara T, Murata M, Ogata Y, et al
    Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy.
    Ann Nucl Med. 2017;31:399-406.
    PubMed     Text format     Abstract available


  117. SHIMIZU S, Hirose D, Namioka N, Kanetaka H, et al
    Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.
    Ann Nucl Med. 2017;31:390-398.
    PubMed     Text format     Abstract available


  118. KUNIKOWSKA J, Pawlak D, Bak MI, Kos-Kudla B, et al
    Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.
    Ann Nucl Med. 2017;31:347-356.
    PubMed     Text format     Abstract available


    May 2017
  119. IMABAYASHI E, Soma T, Sone D, Tsukamoto T, et al
    Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Ann Nucl Med. 2017 May 25. doi: 10.1007/s12149-017-1181.
    PubMed     Text format     Abstract available


  120. AKTAN M, Koc M, Kanyilmaz G, Yavuz BB, et al
    Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer.
    Ann Nucl Med. 2017 May 17. doi: 10.1007/s12149-017-1178.
    PubMed     Text format     Abstract available


  121. KIM JW, Seo S, Kim HS, Kim DY, et al
    Erratum to: Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.
    Ann Nucl Med. 2017 May 11. doi: 10.1007/s12149-017-1179.
    PubMed     Text format    


  122. TORIIHARA A, Nakajima R, Arai A, Nakadate M, et al
    Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.
    Ann Nucl Med. 2017 May 11. doi: 10.1007/s12149-017-1180.
    PubMed     Text format     Abstract available


  123. SUZUKI H, Kato K, Nishio M, Tamaki T, et al
    FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study.
    Ann Nucl Med. 2017 May 3. doi: 10.1007/s12149-017-1176.
    PubMed     Text format     Abstract available


  124. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Characteristics of single- and dual-photopeak energy window acquisitions with thallium-201 IQ-SPECT/CT system.
    Ann Nucl Med. 2017 May 3. doi: 10.1007/s12149-017-1177.
    PubMed     Text format     Abstract available


  125. SADEGHZADEH M, Alirezapour B, Charkhlooie GA, Baghery MK, et al
    Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine as a breast tumor imaging tracer in mouse.
    Ann Nucl Med. 2017;31:335-346.
    PubMed     Text format     Abstract available


  126. MOSLEMI V, Ashoor M
    Design and performance evaluation of a new high energy parallel hole collimator for radioiodine planar imaging by gamma cameras: Monte Carlo simulation study.
    Ann Nucl Med. 2017;31:324-334.
    PubMed     Text format     Abstract available


    April 2017
  127. KOIZUMI M, Motegi K, Koyama M, Terauchi T, et al
    Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
    Ann Nucl Med. 2017 Apr 29. doi: 10.1007/s12149-017-1175.
    PubMed     Text format     Abstract available


  128. WENG CC, Huang SL, Chen ZA, Lin KJ, et al
    [18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.
    Ann Nucl Med. 2017 Apr 27. doi: 10.1007/s12149-017-1174.
    PubMed     Text format     Abstract available


  129. KIM JW, Seo S, Kim HS, Kim DY, et al
    Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.
    Ann Nucl Med. 2017 Apr 25. doi: 10.1007/s12149-017-1171.
    PubMed     Text format     Abstract available


  130. WATABE T, Hanaoka K, Naka S, Kanai Y, et al
    Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET.
    Ann Nucl Med. 2017 Apr 24. doi: 10.1007/s12149-017-1172.
    PubMed     Text format     Abstract available


  131. KONISHI T, Nakajima K, Okuda K, Yoneyama H, et al
    IQ-SPECT for thallium-201 myocardial perfusion imaging: effect of normal databases on quantification.
    Ann Nucl Med. 2017 Apr 12. doi: 10.1007/s12149-017-1170.
    PubMed     Text format     Abstract available


  132. YAMAMOTO H, Arimura S, Nakanishi A, Shimo Y, et al
    Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT.
    Ann Nucl Med. 2017 Apr 5. doi: 10.1007/s12149-017-1168.
    PubMed     Text format     Abstract available


  133. HASHIMOTO T, Yokota C, Koshino K, Temma T, et al
    Binding of 11C-Pittsburgh compound-B correlated with white matter injury in hypertensive small vessel disease.
    Ann Nucl Med. 2017;31:227-234.
    PubMed     Text format     Abstract available


  134. KURISU S, Higaki T, Sumimoto Y, Ikenaga H, et al
    Aortic knob width reflects left ventricular diastolic function assessed by gated myocardial perfusion single photon emission computed tomography in patients with normal myocardial perfusion.
    Ann Nucl Med. 2017;31:245-249.
    PubMed     Text format     Abstract available


  135. GENDRE R, Lairez O, Mondoly P, Duparc A, et al
    Research of predictive factors for cardiac resynchronization therapy: a prospective study comparing data from phase-analysis of gated myocardial perfusion single-photon computed tomography and echocardiography : Trying to anticipate response to CRT.
    Ann Nucl Med. 2017;31:218-226.
    PubMed     Text format     Abstract available


  136. MIKI T, Shimada H, Kim JS, Yamamoto Y, et al
    Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
    Ann Nucl Med. 2017;31:260-272.
    PubMed     Text format     Abstract available


  137. MISAKA T, Hosono M, Kudo T, Ito T, et al
    Influence of acquisition orbit on phase analysis of gated single photon emission computed tomography myocardial perfusion imaging for assessment of left ventricular mechanical dyssynchrony.
    Ann Nucl Med. 2017;31:235-244.
    PubMed     Text format     Abstract available


  138. WATANABE S, Nakajima K, Mizokami A, Yaegashi H, et al
    Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Ann Nucl Med. 2017;31:201-210.
    PubMed     Text format     Abstract available


    March 2017
  139. SINGNURKAR A, Poon R, Metser U
    Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review.
    Ann Nucl Med. 2017 Mar 28. doi: 10.1007/s12149-017-1164.
    PubMed     Text format     Abstract available


  140. KROISS AS, Uprimny C, Shulkin BL, Frech A, et al
    Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma.
    Ann Nucl Med. 2017 Mar 27. doi: 10.1007/s12149-017-1162.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: